Ulla Margrete Hansen
Affiliations: | 1983-1997 | Microbiology and Molecular Genetics | Harvard Medical School, Boston, MA, United States |
| 1998- | Biology | Boston University, Boston, MA, United States |
Area:
Mammalian gene regulation, Transcription, Cell cycle, CancerWebsite:
https://www.bu.edu/biology/people/profiles/ulla-hansen/Google:
"Ulla Margrete Hansen"Bio:
https://scholar.google.com/citations?hl=en&user=foGYVIkAAAAJ
http://www.jbc.org/content/254/13/5713.short
http://www.jbc.org/content/255/20/9556.short
http://www.jbc.org/content/255/20/9564.short
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| William Robert McClure | grad student | 1980 | Harvard | |
| (Mechanism of action of the sigma subunit of Escherichia coli RNA polymerase.) | ||||
Children
Sign in to add trainee| Wendy Hanna-Rose | grad student | 1996 | Harvard |
| Jelena Veljkovic | grad student | 2005 | Boston University (MathTree) |
| Karen J. Repetny | grad student | 2006 | Boston University (MathTree) |
| Adnan Derti | grad student | 2007 | Boston University (MathTree) |
| Raegan B. O'Lone | grad student | 2007 | Boston University (MathTree) |
| Nan Zhu | grad student | 2007 | Boston University (MathTree) |
| Roxanne G. Cacioppo | grad student | 2008 | Boston University (MathTree) |
| Utsav H. Saxena | grad student | 2009 | Boston University (MathTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Willoughby JLS, George K, Roberto MP, et al. (2020) Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence. Bmc Cancer. 20: 552 |
| Chin HG, Esteve PO, Ruse C, et al. (2020) The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates α-tubulin. The Journal of Biological Chemistry |
| Pokharel N, Kavouris J, Biagi J, et al. (2020) Abstract 4021: Assessing the sensitivity of LSF inhibitors against liver cancer Cancer Research. 80: 4021-4021 |
| Acevedo-Luna N, Mariño-Ramírez L, Halbert A, et al. (2016) Most of the tight positional conservation of transcription factor binding sites near the transcription start site reflects their co-localization within regulatory modules. Bmc Bioinformatics. 17: 479 |
| Chin HG, Ponnaluri VK, Zhang G, et al. (2016) Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression. Oncotarget |
| Rajasekaran D, Siddiq A, Willoughby JL, et al. (2015) Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model. Oncotarget |
| Bernelot Moens SJ, Schnitzler GR, Nickerson M, et al. (2012) Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation. 126: 1993-2004 |
| Santhekadur PK, Rajasekaran D, Siddiq A, et al. (2012) The transcription factor LSF: a novel oncogene for hepatocellular carcinoma. American Journal of Cancer Research. 2: 269-85 |
| Grant TJ, Bishop JA, Christadore LM, et al. (2012) Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 109: 4503-8 |
| Schneider S, Smith T, Hansen U. (2012) SCOREM: statistical consolidation of redundant expression measures. Nucleic Acids Research. 40: e46 |